Experienced in Respiratory Syncytial Virus (RSV) Infection

Nelson S. Lee

Toronto, ON, CA 
Experienced in Respiratory Syncytial Virus (RSV) Infection
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Nelson Lee practices in Toronto, Canada. Mr. Lee is rated as an Experienced expert by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. His top areas of expertise are Flu, Avian Influenza, Parainfluenza, and Pneumonia.

His clinical research consists of co-authoring 111 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Respiratory Syncytial Virus (RSV) Infection.

Gender
Male

Locations

Toronto, ON, Canada
Other Locations
Edmonton, AB, Canada
Canada
Hong Kong, China
Sar, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
Enrollment Status: Unknown
Publish Date: October 13, 2023
Intervention Type: Drug
Study Drugs: IFN-Beta1a, Remdesivir
Study Phase: Phase 3

112 Total Publications

Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada.
Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada.
Journal: Vaccine
Published: January 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lee's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile